Xtelligence Inc.
----Coming Soon----
A New Standard in Enzyme Technology
Revolutionizing industrial enzyme applications through intracellular protein crystallization technology.
We drive societal progress by enabling industrial enzyme applications that were previously impossible to manufacture or deploy with conventional methods.
Using our intracellular protein crystallization technology—Protein Crystal Material (PCM)—we solve our customers’ most pressing challenges.
Revolutionizing industrial enzyme applications through intracellular protein crystallization technology.
We drive societal progress by enabling industrial enzyme applications that were previously impossible to manufacture or deploy with conventional methods.
Using our intracellular protein crystallization technology—Protein Crystal Material (PCM)—we solve our customers’ most pressing challenges.
who we are
about us
Leveraging the core technologies and know-how developed through cutting-edge R&D in Professor Takafumi Ueno’s laboratory at the Institute of Science Tokyo, we will launch the spin-off startup in April 2026.
who we are
about us
Leveraging the core technologies and know-how developed through cutting-edge R&D in Professor Takafumi Ueno’s laboratory at the Institute of Science Tokyo, we will launch the spin-off startup in April 2026.
Our business
business details
The world’s only intracellular protein crystallization technology solution.
『Protein Crystal Material / PCM』
We manage the end-to-end development of production processes and application technologies for enzymes that were previously difficult to manufacture, achieving rapid commercialization.
Our business
business details
The world’s only intracellular protein crystallization technology solution.
『Protein Crystal Material / PCM』
We manage the end-to-end development of production processes and application technologies for enzymes that were previously difficult to manufacture, achieving rapid commercialization.
We manage the end-to-end development of production processes and application technologies for enzymes that were previously difficult to manufacture, achieving rapid commercialization.
technical Expertise
Technology
By harnessing spontaneous intracellular crystallization of any target protein, our next-generation technology unlocks stability and enhanced functionality in proteins that were previously challenging to develop.
technical Expertise
Technology
By harnessing spontaneous intracellular crystallization of any target protein, our next-generation technology unlocks stability and enhanced functionality in proteins that were previously challenging to develop.
our team
Yo murofushi
Chief of Executive Officer/CEO
takafumi ueno
Chief of Technical Officer/CTO
takumi dobashi
Chief of Sales Officer/CSO
After a career at a leading consulting firm, he founded AND Africa in South Africa in 2017, creating over 10,000 jobs through ECD and other delivery-matching services, and after its liquidation in November 2024 he launched Optys Solutions to work on national drone projects.
Since 2025 he has served as an Entrepreneur-in-Residence at the Tokyo University of Science and holds an M.S. in Applied Biology from Tohoku University.
After earning his Ph.D. from Osaka University’s Graduate School of Science in 1998, he served as a JSPS Special Research Fellow, a researcher at Mitsubishi Chemical Corporation, a Research Assistant at the Institute for Molecular Science, an Assistant Professor at Nagoya University’s Graduate School of Science, and an Associate Professor at Kyoto University’s Institute for Integrated Cell–Material Sciences, before being appointed Professor of the School of Life Science and Applied Chemistry at the Institute of Science Tokyo in March 2012.
He spent 11 years at a leading trading company overseeing HR, B2B sales, and business development, and since 2019 has been responsible for both B2B and B2C business development as well as startup investments. With a mission to create Japanese deep-tech startups, he joined METI’s NEDO-SSA and has served as an Entrepreneur-in-Residence at the Institute of Science Tokyo since 2024. He holds an M.S. in Applied Biology from Kobe University Graduate School.
our team
Yo murofushi
Chief of Executive Officer/CEO
After a career at a leading consulting firm, he founded AND Africa in South Africa in 2017, creating over 10,000 jobs through ECD and other delivery-matching services, and after its liquidation in November 2024 he launched Optys Solutions to work on national drone projects.
Since 2025 he has served as an Entrepreneur-in-Residence at the Tokyo University of Science and holds an M.S. in Applied Biology from Tohoku University.
takafumi ueno
Chief of Technical Officer/CTO
After earning his Ph.D. from Osaka University’s Graduate School of Science in 1998, he served as a JSPS Special Research Fellow, a researcher at Mitsubishi Chemical Corporation, a Research Assistant at the Institute for Molecular Science, an Assistant Professor at Nagoya University’s Graduate School of Science, and an Associate Professor at Kyoto University’s Institute for Integrated Cell–Material Sciences, before being appointed Professor of the School of Life Science and Applied Chemistry at the Institute of Science Tokyo in March 2012.
takumi dobashi
Chief of Sales Officer/CSO
He spent 11 years at a leading trading company overseeing HR, B2B sales, and business development, and since 2019 has been responsible for both B2B and B2C business development as well as startup investments. With a mission to create Japanese deep-tech startups, he joined METI’s NEDO-SSA and has served as an Entrepreneur-in-Residence at the Institute of Science Tokyo since 2024. He holds an M.S. in Applied Biology from Kobe University Graduate School.